BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2022/5603919 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832545949743841280 |
|---|---|
| author | A. K. Ghosh S. Bhushan L. D. R. Lopez D. Sampat Z. Salah C. A. Hatoum |
| author_facet | A. K. Ghosh S. Bhushan L. D. R. Lopez D. Sampat Z. Salah C. A. Hatoum |
| author_sort | A. K. Ghosh |
| collection | DOAJ |
| description | Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course. |
| format | Article |
| id | doaj-art-c9dcbca354d94408bff8f867ec1070a0 |
| institution | Kabale University |
| issn | 1687-9635 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-c9dcbca354d94408bff8f867ec1070a02025-02-03T07:24:16ZengWileyCase Reports in Medicine1687-96352022-01-01202210.1155/2022/5603919BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic PurpuraA. K. Ghosh0S. Bhushan1L. D. R. Lopez2D. Sampat3Z. Salah4C. A. Hatoum5Northeast Georgia Medical CenterNortheast Georgia Medical CenterNortheast Georgia Medical CenterHematology/Oncology FacultyInternal Medicine FacultyInternal Medicine FacultyImmune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.http://dx.doi.org/10.1155/2022/5603919 |
| spellingShingle | A. K. Ghosh S. Bhushan L. D. R. Lopez D. Sampat Z. Salah C. A. Hatoum BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura Case Reports in Medicine |
| title | BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura |
| title_full | BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura |
| title_fullStr | BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura |
| title_full_unstemmed | BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura |
| title_short | BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura |
| title_sort | bnt162b2 covid 19 vaccine induced immune thrombocytopenic purpura |
| url | http://dx.doi.org/10.1155/2022/5603919 |
| work_keys_str_mv | AT akghosh bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura AT sbhushan bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura AT ldrlopez bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura AT dsampat bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura AT zsalah bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura AT cahatoum bnt162b2covid19vaccineinducedimmunethrombocytopenicpurpura |